About: covid:PMC7291857

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7291857 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Vatrella, Alessandro Pagliano, Pasquale Filippelli, Amelia Vecchione, Carmine Selleri, Carmine Borrelli, Anna Cuffa, Bianca Gammaldi, Renato Giudice, Valentina Maglio, Angelantonio Masullo, Alfonso Polverino, Benedetto Poto, Sergio Sellitto, Carmine Serio, Bianca Vitale, Carolina
is schema:about of	named entity 'Eculizumab' named entity 'SARS-CoV-2' named entity 'Acute Respiratory Distress Syndrome' named entity 'Acute Respiratory Distress Syndrome' named entity 'Eculizumab' named entity 'SARS-CoV-2' named entity 'ARDS' named entity 'kinin' named entity 'inflammation' named entity 'unilateral or bilateral' named entity 'Etic' named entity 'pneumonia' named entity 'immune responses' named entity 'PaO2' named entity 'lactate dehydrogenase' named entity 'ARDS' named entity 't-tests' named entity 'myelofibrosis' named entity 'ruxolitinib' named entity 'COVID-19' named entity 'ruxolitinib' named entity 'non-Hodgkin' named entity 'kinin' named entity 'cytopenia' named entity 'COVID' named entity 'kinin' named entity 'IL-1' named entity 'pneumococcal meningitis' named entity 'eculizumab' named entity 'eculizumab' named entity 'virus' named entity 'acute respiratory distress syndrome' named entity 'tuberculosis' named entity '8/10' named entity 'COVID' named entity 'creatinine levels' named entity 'eculizumab' named entity 'clinical protocol' named entity 'ruxolitinib' named entity 'infection' named entity 'life-threatening' named entity 'eculizumab' named entity 'alveolar epithelial cells' named entity 'ARDS' named entity 'thrombosis' named entity 'QT prolongation' named entity 'ARDS' named entity 'C5a' named entity 'carbon-dioxide' named entity 'IL-6' named entity 'platelet count' named entity 'Salerno' named entity 'informed consent' named entity 'breastfeeding' named entity 'ARDS' named entity 'intensive care' named entity 'ARDS' named entity 'meningococcal infection' named entity 'infection' named entity 'ruxolitinib' named entity 'ARDS' named entity 'infection' named entity 'National Cancer Institute' named entity 'SARS-CoV-2' named entity 'antivirals' named entity 'La Jolla' named entity 't-test' named entity 'invasive mechanical ventilation' named entity 'prophylaxis' named entity 'eculizumab' named entity 'dog' named entity 'infection' named entity 'ruxolitinib' named entity 'heparin' named entity 'Post-hoc analysis' named entity 'hemoglobin' named entity 'eculizumab' named entity 'viral entry' named entity 'subcutaneous' named entity 'type I interferons' named entity 'PaO2/FiO2 ratio' named entity 'SARS-CoV-2' named entity 'RT-PCR' named entity 'immune responses'

Attributes

Values

Creator

Vatrella, Alessandro
Pagliano, Pasquale
Filippelli, Amelia
Vecchione, Carmine
Selleri, Carmine
Borrelli, Anna
Cuffa, Bianca
Gammaldi, Renato
Giudice, Valentina
Maglio, Angelantonio
Masullo, Alfonso
Polverino, Benedetto
Poto, Sergio
Sellitto, Carmine
Serio, Bianca
Vitale, Carolina

is schema:about of

named entity 'Eculizumab'
named entity 'SARS-CoV-2'
named entity 'Acute Respiratory Distress Syndrome'
named entity 'Acute Respiratory Distress Syndrome'
named entity 'Eculizumab'
named entity 'SARS-CoV-2'
named entity 'ARDS'
named entity 'kinin'
named entity 'inflammation'
named entity 'unilateral or bilateral'
named entity 'Etic'
named entity 'pneumonia'
named entity 'immune responses'
named entity 'PaO2'
named entity 'lactate dehydrogenase'
named entity 'ARDS'
named entity 't-tests'
named entity 'myelofibrosis'
named entity 'ruxolitinib'
named entity 'COVID-19'
named entity 'ruxolitinib'
named entity 'non-Hodgkin'
named entity 'kinin'
named entity 'cytopenia'
named entity 'COVID'
named entity 'kinin'
named entity 'IL-1'
named entity 'pneumococcal meningitis'
named entity 'eculizumab'
named entity 'eculizumab'
named entity 'virus'
named entity 'acute respiratory distress syndrome'
named entity 'tuberculosis'
named entity '8/10'
named entity 'COVID'
named entity 'creatinine levels'
named entity 'eculizumab'
named entity 'clinical protocol'
named entity 'ruxolitinib'
named entity 'infection'
named entity 'life-threatening'
named entity 'eculizumab'
named entity 'alveolar epithelial cells'
named entity 'ARDS'
named entity 'thrombosis'
named entity 'QT prolongation'
named entity 'ARDS'
named entity 'C5a'
named entity 'carbon-dioxide'
named entity 'IL-6'
named entity 'platelet count'
named entity 'Salerno'
named entity 'informed consent'
named entity 'breastfeeding'
named entity 'ARDS'
named entity 'intensive care'
named entity 'ARDS'
named entity 'meningococcal infection'
named entity 'infection'
named entity 'ruxolitinib'
named entity 'ARDS'
named entity 'infection'
named entity 'National Cancer Institute'
named entity 'SARS-CoV-2'
named entity 'antivirals'
named entity 'La Jolla'
named entity 't-test'
named entity 'invasive mechanical ventilation'
named entity 'prophylaxis'
named entity 'eculizumab'
named entity 'dog'
named entity 'infection'
named entity 'ruxolitinib'
named entity 'heparin'
named entity 'Post-hoc analysis'
named entity 'hemoglobin'
named entity 'eculizumab'
named entity 'viral entry'
named entity 'subcutaneous'
named entity 'type I interferons'
named entity 'PaO2/FiO2 ratio'
named entity 'SARS-CoV-2'
named entity 'RT-PCR'
named entity 'immune responses'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software